LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the formation of an Expert Oncology Panel to provide guidance on research and development strategies for the Company’s portfolio of novel oncology therapies.
Help employers find you! Check out all the jobs and post your resume.
